THE DEAL, AT A GLANCE
From the announcementSunshine Biopharma
01Who is involvedBacked by the offering for general corporate purposes, working capitalFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedSunshine Biopharma raised $6M Series D, announced 2026-10-09From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersSunshine Biopharma closed a $6 million best efforts public offering on October 9, 2026, adding gross proceeds for general corporate purposes and working capital.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Sunshine Biopharma · Financing Record
Explore source-linked visual explanations for Sunshine Biopharma. Unsupported claims are withheld while source review continues.
Record 13892 · Recorded date: 2026-10-09
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →